Esophageal stents are used to open a patient esophagus and assist in swallowing food and liquid content. In terms of end-user, the market has been segmented into hospitals, specialty clinics, and ambulatory surgery centers. Gastrointestinal stents https://www.toiletstool.net are also placed non-endoscopically by radiologists. Europe is the second largest market for gastrointestinal stents.0 per 100,000 men and women per year. Based on application, the gastrointestinal stents market has been categorized into colorectal cancer, inflammatory bowel disease, gastrointestinal bleeding, and others.However, stringent regulation for product approval is expected to hamper the growth of the gastrointestinal stents market.The gastrointestinal stents market has been segmented based on product type, application, end-user, and region.
The basic principles of stent insertion involve initial placement of a guidewire across the region to be stented, using endoscopic vision and often fluoroscopic guidance too. Latin America and Middle East & Africa will create large opportunity due to developing health care infrastructure, increasing number of private insurance coverage, and growing awareness among people.In terms of product type, the market has been classified into bile duct stents, esophageal stents, duodenal stents, and colonic stents.
Major players operating in this market include Becton, Dickinson and Company, Boston Scientific Corporation, Medtronic, Inc.Highlights of the report:A complete backdrop analysis, which includes an assessment of the parent market.Important changes in market dynamics.Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume.Reporting and evaluation of recent industry developments.
Market projections for the coming years Key highlights of this report.Overview of key market forces propelling and restraining market growth.Up-to-date analyses of market trends and technological improvements.Pin-point analyses of market competition dynamics to offer you a competitive edge.An analysis of strategies of major competitors.An array https://www.toiletstool.net of graphics and SWOT analysis of major industry segments.Detailed analyses of industry trends.A well-defined technological growth map with an impact-analysis.Offers a clear understanding of the competitive landscape and key product segments.Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services.It does this so evaluating the forces and the trends predominant over the last couple of years and also the ones that are expected to put an impact on the market during the forecast period.The global market for personal care is expected to witness substantial growth over the coming years owing to the growing disposable income of consumers, thus enabling them to spend on luxury personal care products. North America and Europe are also likely to provide lucrative growth opportunities.
These appliances comprise electric toothbrushes, trimmers, massagers, curlers, flat irons, blow dryers, hair setters, and hair clippers. The Porter’s five forces analysis has been considered by the analysts to present a clear conception of the vendor landscape to the ones reading the report. Personal care appliances have become popular across the globe in the last few years owing to the penetration of new and innovative appliances in the market every year. While the personal care products segment for women is a prominent category, the introduction of the men’s product line for grooming has bolstered the growth of the market extensively.Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.The report is an examination in the development of the global personal care market over the last few years and in the upcoming years.The key companies operating in the market are Proctor & Gamble Company, Helen of Troy Ltd. The study further investigates the management and workflow of several leading players and presents readers with information on their products, marketing and production strategies, and market shares of the past and future years.
The market study further details out the reasons of the vicissitudes in the market worldwide. In order to cater to specific customer needs, manufacturers have flooded the market with specific hair and skin products. Asia Pacific is likely to emerge as a prominent region in the market with the changing lifestyle of consumers and incessantly growing population.The personal care industry is the one which produces consumer products that are used for beautification and personal hygiene. The global market for personal care is extremely diversified and can be bifurcated into personal care products and personal care appliances. The subsectors of personal care comprise cosmetics and personal hygiene. Mergers, acquisitions, agreements, and other dealings have also been emphasized in the study.Global Personal Care Market: Regional Outline The global market for personal care can be segmented into North America, Asia Pacific, Europe, and the Rest of the World. The market is also expected to be benefitted by the promotional offers, advertising, and media penetration., Johnson & Johnson, Unilever, Colgate-Palmolive Company, Avon Products, and L’Oréal Paris, among others. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information. In emerging economies, facets such as growing spending power of consumers, abundance of international brands, and rapid urbanization is likely to help in the growth of the market in the near future.
Some of the products that are included in personal care wet wipes, toothpaste, toilet paper, talcum powder, moisturizer, shaving cream, razors, perfumes, pomade, nail files, makeup, lotion, lipstick, lip gloss, hair clippers, facial tissue, eye liner, deodorant, cotton pads, cotton swabs, colognes, and cleansing pods. The segment of personal care products includes skin care, hair care, personal hygiene, oral hygiene, deodorants, fragrances, shower and bath, and make-up.Moreover, the development of improvised and innovative products in the women’s line such as cosmeceutical and multifunctional products is expected to trigger the sales of personal care products in the coming years.
North America and Europe dominate the global cancer biomarkers market on account of high cancer diagnostic and detection procedures, high investment in research and development by pharmaceutical and biotechnology companies and better healthcare infrastructure supporting the R&D activities using biomarkers.About Coherent Market Insights:Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis https://www.toiletstool.net/ through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.On the basis of cancer type, the global caner biomarkers market is segmented into lung cancer, breast cancer, prostate cancer, cervical cancer, colorectal cancer and others. The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer.
The WHO estimates that in 2015 only 35% of the low-income countries reported to have pathology services available in the public sector. Human epidermal growth factor receptor 2 (HER2) is the biomarker highly targeted for breast cancer treatment. Therefore, understanding cancer biomarkers is the key to developing the right treatment plan for a cancer patient. Cancer biomarkers are finding increasing applications in drug discovery with growing research activities on targeted cancer therapies. Other types of cancer biomarkers include ERCC1, BRCA1, BRCA2 and SPARC. These biomarkers can be found in blood, urine, stool, tumor tissue, or other body fluids.There are increasing efforts to diagnose cancer at an early stage, which would drive the global cancer biomarkers market growth.Some of the key players in the global cancer biomarkers market include Abbott Laboratories. There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO).Cancer therapies are expensive and the cost rises with increase in complexity or stage of the caner condition. Biomarkers indicates one’s health condition and the underlying disease condition. Various types of biomolecules such as DNA, proteins, and hormones are widely used to detect the malady.
Roche Diagnostics Ltd, Becton Dickinson and Company, Thermo Fisher Scientific Inc.Omics technologies is widely used profiling technology in the global market.Cancer Biomarkers Market TaxonomyThe global cancer biomarkers market can be segmented on the basis of biomarker type, cancer type, application, and biomarker profiling technologies. These factors highly govern the growth of cancer biomarkers market, as accessibility would enable uptake of this technology by the users.On the basis of application, the market is classified as drug discovery and development, diagnostics, prognostics, risk assessment and others. However, poor reimbursement policies is negatively impacting market growth. The rate is extremely less compared the high-income countries, which reported 90% availability of pathology services. On the basis of biomarker type, the market is segmented into protein biomarker, genetic biomarker and cellular biomarkers, and others. Different cancer biomarkers react differently to various cancer treatments. Growing demand for personalized treatment therapies, use of proteomics in cancer biomarker detection, growing demand for accurate & effective diagnostic procedures are amongst the major factors driving its market growth. Inc.Cancer is the second-leading cause of death worldwide. Enzyme-Linked Immunosorbent Assay (ELISA) is the most widely used immunoassays profiling technology in the global cancer biomarkers industry.On the basis of profiling technology, the market is segmented into omics technologies, imaging technologies, immunoassays, cytogenetic based tests, and bioinformatics. Markets in emerging economies such as the Asia Pacific and Latin America are poised to grow at a considerable higher growth rate owing to increasing funding for cancer biomarker research, growing prevalence of cancer, increasing number of clinical trials and growing demand for targeted and personalized drug therapies.
The solid dosage form segment accounted for the largest share of the market in 2014. However, mu-opioid receptor antagonist was the fastest growing segment due to https://www.toiletstool.net/ recent launch of the new drug Moventik and presence of pipeline drugs (naldemedine and other early stage drugs). This is due to high patient compliance and launch of new drugs in solid form such as capsules, tablets, and pills. Drug classes include mu-opioid receptor antagonist, chloride channel activator, and others based on their mechanism of action. Asia Pacific, Latin America, and Middle East & Africa are the major consumers of traditional medicines used to treat opioid induced constipation due to easy access, low cost, and less awareness about targeted therapy.
The segment is expected to maintain its leadership position during the forecast period.Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. Linaclotide is another potential drug, which is currently in phase II clinical trial.Furthermore, based on dosage form, the market has been segmented into solid, semi-solid, and liquid. Acquisitions and collaborations among major companies to commercialize OIC medicines are expected to boost the market during the forecast period.The report provides detailed analysis of current and emerging drugs for opioid induced constipation treatment, and the market is estimated based on type of drug class and dosage form of the drugs.
The others segment includes Resolor (prucalopride), bulking agents (cellulose and psyllium), stool softeners (docusate), laxatives, and osmotic agents (lactulose, sorbitol.However, monthly cost of Amitiza ranges from US 300 to US 400 and from US 600 to US 1000 for Relistor. Traditional laxatives are not legally approved for the treatment of opioid induced constipation. The chloride channel activator segment accounted for the largest share of the opioid induced constipation treatment market in 2014 due to first approval and launch of Amitiza in major countries.In addition, in October 2014, Takeda and Sucampo entered into global license, development, and commercialization agreement for Amitiza. Presently, Amitiza is the only available drug that belongs to the chloride channel activator class. The number of players operating in the opioid induced constipation treatment market is small, while demand for the therapy is high.
Acute diarrhea is one of the most commonly reported illnesses in the United States. Moreover, diarrhea is known to be a major cause of malnutrition in children, since the disease deprives the child of the nutrition required for their proper growth. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. Prevention of the diarrheal disease can be achieved by drinking of safe water coupled with adequate hygiene and sanitation.The Colon Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colon Cancer and features dormant and discontinued projects. According to the WHO, diarrhea is the second leading cause of death, especially in children less than 5 years of age.

It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Geographically, the global anti diarrheal drugs market can be segmented into four major regions, namely North America, Europe, Asia-Pacific and Rest of the World. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 6, 35, 3, 155 and 14 respectively.

The guide covers the descriptive pharmacological action of the therapeutics, https://www.toiletstool.net its complete research and development history and latest news and press releases.Colon Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 2, 46 and 16 molecules, respectively. Higher prevalence rates of diarrheal disease in developing countries have been observed due to unhygienic and improper sanitation procedures.The report offers a comprehensive evaluation of the market
Value chain and stakeholder analysis.S.Geographically the laxative market is segmented into North America, Latin America, Europe, Asia Pacific and Middle East and Africa.The report has been compiled through extensive primary research (through https://www.toiletstool.net interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). Obesity is also a major factor responsible for constipation, hence rising obese cases are one the major reason for the growth of laxative market.

By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. Sedentary life style includes unhealthy eating habits, less hours of sleep, irregular meal timings and lack of exercise which causes gastric imbalance which can further lead to constipation. U. This helps the patient in better bowel motions through the stoma and collected in special disposable colostomy bag, which fits over the stoma and sticks to the skin. The broad spectrum regarding the causes for the disease is expected to favor the growth in colostomy bags market in the near future. The side effects caused are generally not taken into more consideration as the constipation itself is a troublesome condition., GlaxoSmithKline Consumer Healthcare, Procter & Gamble Company, Purdue Pharma, Sucampo Pharmaceuticals Inc.

Colostomy is a surgical procedure in which an opening is formed by drawing the healthy end of the large intestine or colon by an incision in the anterior abdominal wall and then suturing and setting it into place.. Furthermore, to avoid infections around colostomy bag due to spillage of stool, sweating, dislocation of colostomy bags wide range of accessories are provided, which includes support belts, girdles, deodorizers, skin protective wipes and stoma paste. Countries such as India, Australia and New Zealand are the largest market for laxatives as the lifestyle disorders are very common in these areas due to high dependence of unhealthy diet, lack of exercise and sedentary life.The report offers a comprehensive evaluation of the market.Geographically, the laxatives market can be segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Ascaris lives in the intestine and is passed https://www.toiletstool.net through feces of the infected individual. Ascaris is transmitted by accidental ingestion of food, water and soil contaminated with Ascaris eggs. Ascaris infected individuals often do not show any symptoms. However, mild symptoms such as abdominal discomfort and cough may occur in some individuals. Cough in Ascariasis is generally due to the migration of the worm through the body. Several other symptoms such as, intestinal blockage and impaired growth in children’s are perceptive in case of individuals with chronic Ascaris infection. Diagnosis of Ascariasis infection is done by visual examination of the Ascaris eggs or adult worms in the stool sample under the microscope.

Anthelminthic medications, such as albendazole and mebendazole are highly recommended medications for treatment of Ascaris infection. According to the WHO, children’s with the Ascariasis prevalence exceeding 70% need to be treated once in a year, however, WHO advices a targeted treatment two to three times a year in case the helminthes is harboring an adult.Poor personal hygiene and poor sanitation in underdeveloped countries is the prime factor contributing towards rising prevalence of this disease. However, adults are known to harbor the helminthes at a low intensity whereas the disease is highly prevalent in children’s. Accidental contact with soil contaminated with human feces, including with human fecal matter leads to spread of this disease among humans. Several health education initiatives conducted by CDC and World Health Organization (WHO) to reduce morbidity as opposed to eradicate helminthes is the prime area of concerns. Measures such as, maintenance of personal hygiene, implementing effective sewage disposal systems, avoiding open defection are few of the factors that will help to prevent the disease.

Increasing administration of contaminated water and food has resulted in increasing number of childerns affecting from this diseases. Drugs including, albendazole, levamisole, mebendazole, piperazine, and pyrantel pamoate are the primary drugs used to treat Ascariasis. Pyrantel pamoate, is highly recommended for women’s who are pregnant. However, in some cases broad spectrum antibiotics are also the choice of treatment.By treatment type, the global market for Ascariasis Treatment & Management has been classified into, anti-parasite medications and surgery. Surgery is recommended therapy in case of severe intestinal blockage with Ascaris. Currently, there is no vaccine for treatment of Ascaris infection.On the basis of distribution channel, the global Ascariasis Treatment & Management market is segmented into, hospital pharmacies, retail pharmacies and e-commerce.Get accurate market forecast and analysis on the Ascariasis Treatment & Management Market.
The growing culture of recycling continues to have a positive effect on poverty alleviation, enterprise development as well as economic growth. Further, there is the added environmental benefit of preventing tons of waste from going into landfill sites.Mpact Recycling is responsible for the collection of over 450 000 tonnes of paper each year, received from a number of sources including trolley-preneurs, small businesses, buy-back centres, schools, and communities to name a few.Although work still needs to be done in shifting consumer mind-sets, the average person can contribute considerably towards the push to going green by adhering to recycling practises in their immediate environment.A CSIR study revealed that as much as a quarter of all the municipal waste generated in South Africa comprises mainline recyclables such as glass, paper, cans and plastics. The disposal of these recyclables as municipal waste is compromising the lifespan of the country’s landfills, many of which are running out of space.Everyone should be sorting household, school and office waste into paper, plastic, glass, cans and other. This can easily be done by having different coloured or marked containers and by sorting each day as these items are discarded. The balance of the waste goes into the traditional refuse bin for municipal collections.

If you are looking at being greener around the home, there are a few simple tips that any household can follow:1. Keep waste paper clean and dry, as quality is important for a "https://www.toiletstool.net good end product2. Check to see if Mpact Recycling offers kerbside collections in your area. In the green Ronnie bag that Mpact Recycling provides to over 200,000 homes in Ekurhuleni, City of Johannesburg and City of Tshwane, you can discard newspaper, magazines, catalogues, phone books, old mail, computer paper, envelopes, gift wrapping paper, cardboard, food boxes, shoeboxes, paper towel and toilet paper tubes, as well as paper egg cartons and other forms of paper or board packaging3. Alternatively, the waste paper can also be dropped off at any of the 2,000 Ronnie Banks conveniently located countrywide at schools, communities and churchesHouseholds, schools, shopping centres and offices can also support their local recyclers or trolley-preneurs by putting out the other recyclables (plastic, glass and cans) into clear bags for them to take on their rounds each week. It is through this social entrepreneurship empowerment model, in partnering with local entrepreneurs who help to collect recyclable goods, that South Africans are able to significantly contribute towards the 100, 000 jobs which the Paper Recycling Association of South Africa (PRASA) estimates is created and sustained by the recycling industry.

Mpact is one of the leading paper and plastics packaging businesses in southern Africa, listed on the JSE’s Main Board in the Industrial - Paper and Packaging sector. The Group has leading market positions in southern Africa in recovered paper collection, corrugated packaging, recycled-based cartonboard and containerboard, polyethylene-terephthalate (“PET”) preforms, recycled PET (“rPET”), styrene trays and plastic jumbo bins. These leading market positions allow Mpact to meet the increasing requirements of its customers and achieve economies of scale and cost effectiveness at the various operations. Mpact has 42 operating sites, of which 21 are manufacturing operations, in South Africa, Namibia, Mozambique and Botswana. Sales in South Africa account for approximately 90% of Mpact’s total revenue for the current year while the balance was predominantly to customers in the rest of Africa.
Gastrointestinal stents are used to open up bile ducts, esophagus, small bowel, and colon that may be diseased or infected. These stents are used in different diseases such as colorectal cancer, inflammatory bowel disease, and other gastrointestinal diseases. Stents can hold open strictured areas in the esophagus, the biliary tree, the colon and the gastroduodenal region. Different types of gastrointestinal stents are used based on disease condition. Bile duct stents are placed in patients with cholangiocarcinoma and their function is to allow normal drainage from the pancreas, gallbladder, and liver into the small bowel. Esophageal stents are used to open a patient’s esophagus and assist in swallowing food and liquid content. Duodenal stents are used to sustain content flow through a patient’s small bowel, near the top of the small intestine, when that area is blocked by cancerous tumors.

Colonic stents are used to open points of stricture or narrowing in a patient’s colon when colorectal disease or cancer may be making it difficult for the patient to digest and to pass stool properly. Advanced endoscopy can be used to insert stents into various sites of the gastrointestinal tract. The basic principles of stent insertion involve initial placement of a guidewire across the region to be stented, using endoscopic vision and often fluoroscopic guidance too. Gastrointestinal stents are also placed non-endoscopically by radiologists.Growing preference for minimally invasive procedures, increasing prevalence of gastrointestinal diseases such as colorectal cancer, inflammatory bowel disease, and gastrointestinal bleeding, rising consumption of alcohol and tobacco, and unhealthy lifestyle are projected to fuel the global gastrointestinal stents market.

According to the National Cancer Institute, the number of new cases of colon and rectum cancer was 41.0 per 100,000 men and women per year. Other factors such as growing awareness among people, technological advancement, health care insurance coverage, and rapid population growth are anticipated to augment the global gastrointestinal stents market. However, stringent regulation for product approval is expected to hamper the growth of the gastrointestinal stents market.The gastrointestinal stents market has been segmented based on product type, application, end-user, and region. In terms of product type, the market has been classified into bile duct stents, esophageal stents, duodenal stents, and colonic https://www.toiletstool.net stents. Based on application, the gastrointestinal stents market has been categorized into colorectal cancer, inflammatory bowel disease, gastrointestinal bleeding, and others.

In terms of end-user, the market has been segmented into hospitals, specialty clinics, and ambulatory surgery centers.Geographically, the gastrointestinal stents market has been classified into North America, Latin America, Europe, Asia Pacific, and Middle East T& Africa.North America dominates the gastrointestinal stents market due to high incidence of gastrointestinal disorders and chronic diseases such as colorectal cancer, rectal cancer, severe abdominal diseases medical conditions, and technological advancement. Colorectal cancer is the third most common cancer diagnosed in both men and women in the U.S. According to the American Cancer Society, an estimated 135,430 people will be diagnosed with colorectal cancer in the U.S. and about 50,260 people will die from the disease in 2017. Europe is the second largest market for gastrointestinal stents. The market in Asia Pacific is expected to grow at higher rate due to rising incidence and mortality of colorectal cancer, increasing prevalence of gastrointestinal diseases, health care insurance coverage, and growing health care expenditure. Latin America and Middle East & Africa will create large opportunity due to developing health care infrastructure, increasing number of private insurance coverage, and growing awareness among people.

お気に入り日記の更新

テーマ別日記一覧

まだテーマがありません

日記内を検索